CD200 and breast carcinoma: Furthermore, Erin et al. [20] assessed the role of CD200/CD200R1 signaling in the progression and metastasis of 4THM murine-breast carcinoma using CD200 transgenic (CD200tg) and CD200R1 knock-out (CD200R−/−) mice.